InChI=1S/C49H89NO9/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-26-32-37-44(53)50-41(39-58-49-48(57)47(56)46(55)43(38-51)59-49)45(54)42(52)36-31-25-23-24-28-33-40-34-29-27-30-35-40/h27,29-30,34-35,41-43,45-49,51-52,54-57H,2-26,28,31-33,36-39H2,1H3,(H,50,53)/t41-,42+,43+,45-,46-,47-,48+,49-/m0/s1 |
OVEHNRYPXYOFTE-XAPODPEKSA-N |
[C@H]1([C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O)OC[C@@H]([C@@H]([C@@H](CCCCCCCC=2C=CC=CC2)O)O)NC(CCCCCCCCCCCCCCCCCCCCCCCCC)=O |
|
Outgoing
|
N-[(2S,3S,4R)-1-(α-D-galactosyloxy)-3,4-dihydroxy-11-phenylundecan-2-yl]hexacosanamide
(CHEBI:139221)
has functional parent
α-D-galactose
(CHEBI:28061)
N-[(2S,3S,4R)-1-(α-D-galactosyloxy)-3,4-dihydroxy-11-phenylundecan-2-yl]hexacosanamide
(CHEBI:139221)
is a
α-galactosylceramide
(CHEBI:132148)
|
|
N-[(2S,3S,4R)-1-(α-D-galactopyranosyloxy)-3,4-dihydroxy-11-phenylundecan-2-yl]hexacosanamide
|
N-[(1S,2S,3R)-1-[(α-D-galactopyranosyloxy)methyl]-2,3-dihydroxy-10-phenyldecyl]hexacosanamide
|
IUPAC
|
18641320
|
Reaxys Registry Number
|
Reaxys
|
20616071
|
PubMed citation
|
Europe PMC
|
|